{
  "resourceType": "AdministrableProductDefinition",
  "id": "novartis-pharmaceuticals-corporation-carbamazepine-735-USA-APD",
  "meta": {
    "profile": [
      "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
    ]
  },
  "status": "active",
  "formOf": [
    {
      "reference": "MedicinalProductDefinition/novartis-pharmaceuticals-corporation-carbamazepine-735-USA-MPD"
    }
  ],
  "administrableDoseForm": {
    "coding": [
      {
        "code": "100000073362",
        "system": "https://spor.ema.europa.eu/v1/lists/200000000004",
        "display": "Oral suspension"
      }
    ]
  },
  "unitOfPresentation": {
    "coding": [
      {
        "code": "200000022814",
        "system": "https://spor.ema.europa.eu/v1/lists/200000000014",
        "display": "Other"
      }
    ]
  },
  "producedFrom": [
    {
      "reference": "ManufacturedItemDefinition/novartis-pharmaceuticals-corporation-carbamazepine-735-USA-MID"
    }
  ],
  "routeOfAdministration": [
    {
      "code": {
        "coding": [
          {
            "code": "100000073619",
            "system": "https://spor.ema.europa.eu/v1/lists/100000073345",
            "display": "Oral use"
          }
        ]
      }
    }
  ]
}
